Celldex Therapeutics, Inc. Construction in Progress Expenditures Incurred but Not yet Paid
Celldex Therapeutics, Inc. (CLDX) reported Construction in Progress Expenditures Incurred but Not yet Paid of $577.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid · last filed 2026-08-06
- Celldex Therapeutics, Inc. construction in progress expenditures incurred but not yet paid for the quarter ending 2026-06-30 was -$376.00K.
- Celldex Therapeutics, Inc. construction in progress expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $953.00K, a 89.09% increase year-over-year.
- Celldex Therapeutics, Inc. construction in progress expenditures incurred but not yet paid for the quarter ending 2025-12-31 was -$374.00K.
- Celldex Therapeutics, Inc. construction in progress expenditures incurred but not yet paid for the quarter ending 2025-09-30 was $423.00K, a 96.74% increase year-over-year.
- Celldex Therapeutics, Inc. construction in progress expenditures incurred but not yet paid for fiscal 2025 was $98.00K, a 262.96% increase from fiscal 2024.
- Celldex Therapeutics, Inc. construction in progress expenditures incurred but not yet paid for fiscal 2024 was $27.00K, a 64.94% decline from fiscal 2023.
- Celldex Therapeutics, Inc. construction in progress expenditures incurred but not yet paid for fiscal 2023 was $77.00K, a 31.86% decline from fiscal 2022.
- Celldex Therapeutics, Inc. construction in progress expenditures incurred but not yet paid for fiscal 2022 was $113.00K, a 60.90% decline from fiscal 2021.
| Period end | Construction in Progress Expenditures Incurred but Not yet Paid 3 month | Construction in Progress Expenditures Incurred but Not yet Paid 6 month | Construction in Progress Expenditures Incurred but Not yet Paid 9 month | Construction in Progress Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$376.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $577.00K 10-Q · filed 2026-08-06 | $203.00K derived: sum of 3 quarters · filed 2026-08-06 | $626.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $953.00K 10-Q · filed 2026-05-07 | $579.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.00M derived: sum of 3 quarters · filed 2026-05-07 | $547.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$374.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $49.00K derived: sum of 2 quarters · filed 2026-02-25 | -$406.00K derived: sum of 3 quarters · filed 2026-08-06 | $98.00K 10-K · filed 2026-02-25 |
| 2025-09-30 | $423.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$32.00K derived: sum of 2 quarters · filed 2026-08-06 | $472.00K 10-Q · filed 2025-11-10 | $267.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$455.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $49.00K 10-Q · filed 2026-08-06 | -$156.00K derived: sum of 3 quarters · filed 2026-08-06 | $59.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $504.00K 10-Q · filed 2026-05-07 | $299.00K derived: sum of 2 quarters · filed 2026-05-07 | $514.00K derived: sum of 3 quarters · filed 2026-05-07 | $426.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$205.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $10.00K derived: sum of 2 quarters · filed 2026-02-25 | -$78.00K derived: sum of 3 quarters · filed 2026-02-25 | $27.00K 10-K · filed 2026-02-25 |
| 2024-09-30 | $215.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $127.00K derived: sum of 2 quarters · filed 2025-11-10 | $232.00K 10-Q · filed 2025-11-10 | -$179.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | -$88.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $17.00K 10-Q · filed 2025-08-07 | -$394.00K derived: sum of 3 quarters · filed 2026-02-25 | $48.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $105.00K 10-Q · filed 2025-05-08 | -$306.00K derived: sum of 2 quarters · filed 2026-02-25 | $136.00K derived: sum of 3 quarters · filed 2026-02-25 | $48.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$411.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $31.00K derived: sum of 2 quarters · filed 2026-02-25 | -$57.00K derived: sum of 3 quarters · filed 2026-02-25 | $77.00K 10-K · filed 2026-02-25 |
| 2023-09-30 | $442.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $354.00K derived: sum of 2 quarters · filed 2024-11-06 | $488.00K 10-Q · filed 2024-11-06 | $563.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$88.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $46.00K 10-Q · filed 2024-08-08 | $121.00K derived: sum of 3 quarters · filed 2025-02-27 | $105.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $134.00K 10-Q · filed 2024-05-06 | $209.00K derived: sum of 2 quarters · filed 2025-02-27 | $193.00K derived: sum of 3 quarters · filed 2025-02-27 | $194.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $59.00K derived: sum of 2 quarters · filed 2025-02-27 | $60.00K derived: sum of 3 quarters · filed 2025-02-27 | $113.00K 10-K · filed 2025-02-27 |
| 2022-09-30 | -$16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$15.00K derived: sum of 2 quarters · filed 2023-11-02 | $38.00K 10-Q · filed 2023-11-02 | $281.00K derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $54.00K 10-Q · filed 2023-08-08 | $297.00K derived: sum of 3 quarters · filed 2024-02-26 | |
| 2022-03-31 | $53.00K 10-Q · filed 2023-05-04 | $296.00K derived: sum of 2 quarters · filed 2024-02-26 | ||
| 2021-12-31 | $243.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $289.00K 10-K · filed 2024-02-26 | ||
| 2021-09-30 | $46.00K 10-Q · filed 2022-11-09 | |||
| 2020-12-31 | $158.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $199.00K derived: sum of 2 quarters · filed 2023-02-28 | -$241.00K derived: sum of 3 quarters · filed 2023-02-28 | $221.00K 10-K · filed 2023-02-28 |
| 2020-09-30 | $41.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$399.00K derived: sum of 2 quarters · filed 2021-11-09 | $63.00K 10-Q · filed 2021-11-09 | |
| 2020-06-30 | -$440.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $22.00K 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $462.00K 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $25.00K 10-K · filed 2022-02-28 | |||
| 2019-06-30 | -$10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $55.00K 10-Q · filed 2020-08-06 | $76.00K derived: sum of 3 quarters · filed 2021-03-29 | |
| 2019-03-31 | $65.00K 10-Q · filed 2020-05-06 | $86.00K derived: sum of 2 quarters · filed 2021-03-29 | ||
| 2018-12-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $107.00K 10-K · filed 2021-03-29 | ||
| 2018-09-30 | $86.00K 10-Q · filed 2019-11-12 | |||
| 2018-03-31 | $212.00K 10-Q · filed 2019-05-07 | $157.00K derived: sum of 2 quarters · filed 2020-03-26 | $145.00K derived: sum of 3 quarters · filed 2020-03-26 | -$138.00K derived: sum of 4 quarters · filed 2020-03-26 |
| 2017-12-31 | -$55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | -$67.00K derived: sum of 2 quarters · filed 2020-03-26 | -$350.00K derived: sum of 3 quarters · filed 2020-03-26 | $20.00K 10-K · filed 2020-03-26 |
| 2017-09-30 | -$12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$295.00K derived: sum of 2 quarters · filed 2018-11-07 | $75.00K 10-Q · filed 2018-11-07 | |
| 2017-06-30 | -$283.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $87.00K 10-Q · filed 2018-08-08 | ||
| 2017-03-31 | $370.00K 10-Q · filed 2018-05-10 | |||
| 2016-12-31 | $159.00K 10-K · filed 2019-03-07 | |||
| 2015-12-31 | $75.00K 10-K · filed 2018-03-07 | |||
| 2015-06-30 | -$336.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $503.00K 10-Q · filed 2015-08-10 | ||
| 2015-03-31 | $839.00K 10-Q · filed 2015-04-29 | |||
| 2014-12-31 | $1.03M 10-K · filed 2017-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |